Plain-English translation of NCT05514275 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a combination treatment for nasopharyngeal cancer (a type of throat cancer) that hasn't responded well to initial chemotherapy. The combination includes radiation therapy plus two medications: recombinant human . The goal is to see if this combination approach can improve how long patients survive and prevent their cancer from coming back.
Some patients with advanced nasopharyngeal cancer don't respond well to standard initial chemotherapy, and doctors need better treatment options for these patients. This trial is testing whether adding these two specific medications to radiation therapy might work better for people whose cancer proved resistant to standard treatment.
You likely qualify if…
You likely don't qualify if…
You would receive radiation therapy combined with two medications given during your treatment visits. The radiation therapy targets the cancer in your throat and neck area, while the two medications work alongside it to enhance the treatment effect. You would be followed throughout your treatment and then monitored afterward to see how well the combination works and to track any side effects.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China